Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 521 - Heterocyclic compounds containing unspecified hetero rings
Patents for C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)
12/2007
12/27/2007US20070299263 Hydroxy Alkyl Amines
12/26/2007EP1539708B1 Benzimidazolones and their use as cytokine inhibitors
12/26/2007CN100357297C Pyrimidines, methods for the production thereof, and use thereof
12/26/2007CN100357275C N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
12/26/2007CN100357270C D-proline derivative
12/21/2007WO2005030712A8 Thrombin receptor antagonists
12/20/2007US20070293498 used for the treatment of cachexia and other weight loss disorders, such as those resulting from cancer, HIV, old age and anorexia nervosa
12/20/2007US20070293487 Benzothiazole- and benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors
12/19/2007EP1406872B1 Dipeptidyl peptidase inhibitors for the treatment of diabetes
12/19/2007EP1326856B1 Pyridine derivatives with ikb-kinase (ikk-beta) inhibiting activity
12/19/2007CN100355714C Arylpiperazines having 5-hydroxyl-typtamine activity
12/18/2007US7309800 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors
12/18/2007US7309702 4-(3-Phenyl-3-carbocycloylpropyl)-1-phenyl- or pyridylpiperazine derivatives: 1-(2-methoxyphenyl)-4-[3-(benzoyl)-3-(phenyl)propyl]piperazine oxalate; serotonin receptor antagonists; Alzheimer's disease
12/11/2007CA2393271C Retroviral protease inhibiting compounds
12/06/2007WO2007138307A2 Process for removing sulfur-containing acids from crude oil
12/06/2007US20070281968 Compounds Derived From Artesunate, Preparation Process, Pharmaceutical Composition And Use Of The Respective Medicine
12/06/2007US20070281946 Tri(cyclo) substituted amide compounds
12/05/2007EP1862451A1 Adamantane derivatives for the treatment of inflammatory diseases
12/05/2007EP1438294B1 Developer constituents and their use for dying keratin fibers
12/05/2007EP1362844B1 Benzylamine analogue
12/05/2007EP1208085B1 Benzanilides as potassium channel openers
12/04/2007US7304094 Alzheimer's disease, modulate the processing of amyloid precursor protein by gamma-secretase
12/04/2007US7304083 2-iminoimidazole derivatives (2)
12/04/2007CA2280753C 1,4-substituted cyclic amine derivatives
12/04/2007CA2202495C Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production
11/2007
11/29/2007WO2007134958A1 Thiazolo-pyramidine / pyridine urea derivatives as adenosine a2b receptor antagonists
11/29/2007US20070276138 Modulators of peroxisome proliferator activated receptors
11/29/2007CA2651769A1 Thiazolo-pyramidine / pyridine urea derivatives as adenosine a2b receptor antagonists
11/27/2007US7300936 α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors
11/27/2007CA2374251C Preparation and use of ionic liquids in microwave-assisted chemical transformations
11/22/2007US20070270444 (5-Methyl-2H-pyrazol-3-yl)-(2-phenylsulfanyl-quinazolin-4-yl)-amine; Anticancer agents; antidiabetic agents; Alzheimer's disease; inhibitors of Aurora-2 and GSK-3
11/21/2007EP1421062B1 Novel cyclohexyl sulphones
11/20/2007US7297818 Adamantane derivatives
11/20/2007US7297802 Nitrogen compounds, formed by condensing carbocyclic, hydroxy ethers such as 3-(2',4'-difluorophenyl)-3,4-epoxy-2-butanol, with 1,2,4-triazole in the presence of bases; fungicides
11/14/2007CN101070304A Quinoline derivatives and their use as mycrobacterial inhibitors
11/13/2007US7294644 CB 1 receptor inverse agonists
11/13/2007CA2231052C Benzoxazepine compounds, their production and use as lipid lowering agents
11/13/2007CA2213080C 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
11/08/2007US20070259892 e.g. 1,3-benzothiazol-2-yl (2-chloral -4-pyrimidinyl)acetonitrile; Jun N -terminal kinase inhibitor; anticarcinogenic agent; neuronal disorders, autoimmune diseases, cardiovascular disordres
11/06/2007USRE39916 Compounds that modulate PPAR activity and methods for their preparation
11/06/2007US7291624 Enzyme inhibitors as drugs for cardiovascular disorders, aids, alzheimers disease or urogenital disorders
11/06/2007CA2388564C Caspase inhibitor
11/06/2007CA2180533C Process for producing aromatic or heteroaromatic sulfur compounds
11/01/2007US20070255063 Benzothiazole- and benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors
10/2007
10/31/2007EP1286998B2 Oxazolidinone derivatives with antibiotic activity
10/31/2007EP1144384B1 Compounds which inhibit leukocyte adhesion mediated by vla-4
10/31/2007CN100345844C Quinazoline derivatives for the treatment of tumours
10/31/2007CN100345841C Preparation for the production of 1,2,4-triazolymethyl-oxiranes
10/30/2007US7288547 CDK-inhibitory 2-heteroaryl-pyrimidines, their production and use as pharmaceutical agents
10/30/2007US7288541 Propylcarbamate derivatives as inhibitors of serine and cysteine proteases
10/25/2007US20070249645 Such as N-(3-Benzyloxy-phenyl)-N-(4-thiazol-2-yl-pyrimidin-2-yl)-amine; allergic diseases, cancer, neurodegenerative and proliferative disorders, diabetes; inhibitors of GSK-3, Aurora2, and Syk protein kinases
10/25/2007US20070249600 Chemical compounds
10/23/2007US7285662 Therapeutic heterocyclic compounds
10/23/2007US7285565 E.g., 3-(2-(4-[(2-aminosulfonyl)phenyl]benzoylamino)phenoxy)benzamidine; 7-(2-(4-[(2-aminosulfonyl)phenyl]benzoylamino)-4-trifluoromethylphenoxy)1-aminoisoquinoline; and 3-hydroxycarbonyl-2-(4-[(2-aminosulfonyl)phenyl]phenylcarbonylamino)phenoxynaphthalene; highly selective
10/23/2007US7285554 Pyrazole derivative
10/23/2007US7285551 For use as therapeutic agent and prophylactic agent for hepatitis C
10/18/2007US20070244109 1-{3-[(6-amino-5-nitropyridin-2-yl)amino]propyl}-4-(2,4-dichlorophenyl)-N-[(1S)-2-hydroxy-1-methylethyl]-1H-pyrrole-3-carboxamide; Antidiabetic, hypotensive, antiischemic, anticarcinogenic agents; Alzheimer*s disease, obesity, polycystic ovary syndrome; brain, neurodegenerative and autoimmune diseases
10/17/2007EP1341769B1 Bacterial gyrase inhibitors and uses thereof
10/17/2007CN100343258C Novel 4-amino-5,6-substituted thiopheno 2,3-d]pyrimidines
10/17/2007CN100343249C 2,4,4-trisubstituted-1,3-dioxolane antifungals
10/16/2007CA2419194C Cyclopentyl modulators of chemokine receptor activity
10/11/2007US20070238754 1-Cyclohexylmethyl-5-(2,5-dimethoxy-phenyl)-2-methyl-1H-pyrrole-3-carboxylic acid cyclohexylamide and 2-(5-Chloro-2-methoxy-phenyl)-1-(2-cyclohexyl-ethyl)-5-methyl-1H-imidazole-4-carboxylic acid cyclohexylamide; treating obesity, eating disorders; antidiabetic agents; antiinflammatory agents; drug abuse
10/11/2007DE60022050C5 Metabotrope glutamatrezeptorantagonisten zur behandlung von krankheiten des zentralen nervensystems Metabotropic glutamate receptor antagonists for treating diseases of the central nervous system
10/10/2007EP1841741A1 Piperidine derivatives as prodrugs of potassium channel inhibitors
10/10/2007EP1539724B1 Amino benzothiazole compounds with nos inhibitory activity
10/10/2007EP1379525B1 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
10/10/2007EP1232150B1 Urea derivatives as anti-inflammatory agents
10/09/2007US7279581 Diazotization of 4-(1,2,4-triazol-1-ylmethyl)phenylamine hydrochloride, reduction and acidification, reaction with hydrazine hydrochloride and alpha -keto- delta -valerolactone, Fischer indole reaction, hydrolysis, transesterification, conversion of hydroxyl group to dimethylamino group
10/09/2007US7279475 Cytokine inhibitors, useful for treating diseases and pathological conditions involving inflammation such as chronic inflammatory disease; for example, 1-(2-methoxy-5-trifluoromethyl-phenyl)-3-{4-[6-methyl-2-(2-morpholin-4-yl-ethyl)-pyrimidin-4-yloxy]-naphthalen-1-yl}-urea
10/09/2007US7279470 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
10/09/2007US7279467 Benzothiazole-and benzoxazole-4, 7-dione derivatives and their use as dcd25 phosphatase inhibitors
10/09/2007CA1341557C Novel triazole and imidazole compounds
10/03/2007CN101045704A An improved process for preparing pure ondansetron hydrochloride dihydrate
10/02/2007CA2401229C Aryl fused azapolycyclic compounds
10/02/2007CA2203417C Bisarylcarbinol derivatives as inhibitors of leukotriene biosynthesis
09/2007
09/27/2007WO2007108742A1 Novel tetralins as 5-ht6 modulators
09/27/2007US20070225456 Single component, phosphine-free, initiators for ethylene homopolymerization and copolymerization with functionalized co-monomers
09/26/2007EP1276732B1 Amides of r-2-(aminoaryl)-propionic acids for use in theprevention of leucocyte activation"
09/20/2007WO2005030712A3 Thrombin receptor antagonists
09/18/2007US7271196 CETP activity inhibitors
09/18/2007US7271185 Optically active azole derivative and process for producing the same
09/13/2007US20070213369 Novel non-psychotropic cannabinoids
09/13/2007US20070213329 Sulphones which modulate the action of gammasecretase
09/12/2007EP1831158A1 Novel cyclohexane derivatives
09/12/2007EP1395566B1 Tricyclic compounds useful as angiotensin ii agonists
09/12/2007EP1372615A4 Compounds and compositions for delivering active agents
09/11/2007CA2433839C Primary intermediates for oxidative coloration of hair
09/05/2007EP1474419B1 Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes
09/05/2007EP1153016B1 Phenylsulfonyl ureas, methods for producing them and their use as herbicides and plant growth regulators
09/04/2007US7265143 C-4 substituted retinoids
09/04/2007US7265130 anti-obestic activity; Neuropeptide Y antagonist
09/04/2007US7265123 Heterocyclic compounds
08/2007
08/30/2007US20070203193 Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
08/30/2007DE102006007883A1 Verfahren zur Herstellung von Menthylamiden A process for preparing menthylamides
08/29/2007CN100334077C Benzimidazole derivatives and their use as GNRH antagonists
08/28/2007US7262201 Quinazoline derivatives
08/22/2007EP0765304B2 Method of preparing alpha-methoxyiminocarboxylic acid methylamides, and intermediates used in the method
08/22/2007CN1332959C Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
08/21/2007US7259162 Benzazole derivatives and their use as JNK modulators
08/21/2007CA2158487C Weakly basic polymerizable monomers and polymers prepared therefrom
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 ... 163